The Latest Cancer Drugs News
Browsing: Cancer Drug News
Combining two precision medicines can treat drug-resistant cancers
Launching a dual-pronged attack on tumours using a combination of two innovative precision medicines could…
FDA approves pralsetinib for lung cancer with RET gene fusions
The Food and Drug Administration granted accelerated approval to pralsetinib for adult patients with metastatic…
FDA approves azacitidine tablets for acute myeloid leukaemia
On September 1, 2020, the Food and Drug Administration approved azacitidine tablets (ONUREG) for continued…
First drug-like compounds to inhibit elusive cancer-linked enzymes developed
A team of scientists from the University of Michigan Rogel Cancer Center, USA, has developed…
Strong, durable responses to selpercatinib in RET-driven medullary thyroid cancer
Selpercatinib (Retevmo), a drug targeted precisely against cancers driven by mutations or alterations in the…
Phase 1 human trials suggest breast cancer drug is safe and effective
A new type of breast cancer drug developed by researchers at the University of Illinois…
Lung cancer trial of RET inhibitor selpercatinib achieves durable responses in majority of patients with RET gene fusions
For patients with non-small cell lung cancers (NSCLC) marked by RET gene fusions, the targeted…
FDA approves carfilzomib and daratumumab with dexamethasone for multiple myeloma
On August 20, 2020, the Food and Drug Administration approved carfilzomib and daratumumab in combination…
Developing precise medicines for triple negative breast cancer
Taking advantage of a cancer cell’s altered metabolism that drives its runaway growth, Princess Margaret…
Molecule secreted by cancer-associated fibroblasts promotes anticancer drug resistance
A joint project led by Kumamoto University (Japan) has discovered a new mechanism for anticancer…